Skip to content

Application of digital therapy in pulmonary rehabilitation for chronic obstructive pulmonary disease - Cohort study

Application of digital therapy in pulmonary rehabilitation for chronic obstructive pulmonary disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500110100
Enrollment
Unknown
Registered
2025-09-30
Start date
2025-10-15
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute exacerbations of chronic obstructive pulmonary disease

Interventions

Community COPD population:none

Sponsors

Beijing Chao-Yang Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.The patient was diagnosed with COPD, and the lung function was GOLD1-3 grade; 2.Age 45-70 years old; 3.The patients have a smart phone, can use the app skillfully; 4.Willing to follow up and sign informed consent;

Exclusion criteria

Exclusion criteria: 1.They suffer from bronchial asthma, bronchiectasis, tuberculosis of the lungs, thoracic deformity, extreme weakness, impaired vision or balance; 2.They suffer from malignant tumors, liver and kidney failure, osteoarthropathy and other diseases that cause limb movement disorders; 3.Unstable angina attack within one month, acute myocardial infarction within six months, severe arrhythmia, cardiac insufficiency, unsatisfactory blood pressure control in hypertensive patients (high pressure >140mmHg and/or low pressure >90mmHg); 4.Cognition impairment; 5.Combined respiratory failure; 6.The expected survival time is less than 1 year;

Design outcomes

Primary

MeasureTime frame
Acute exacerbation of COPD;

Secondary

MeasureTime frame
Pulmonary function indicators(FEV1?FEV1/FVC?PEF);Acute exacerbation and hospitalization;Anxiety (SAS), and depression (SDS);Symptoms of chronic obstructive pulmonary disease and breathing difficulties;Quality of life (SF-36);Early identification of acute exacerbation;Medication compliance and pulmonary rehabilitation adherence (inhalation drug dosage and timing, implementation of rehabilitation exercises (exercise methods and duration));

Countries

China

Contacts

Public ContactLiang Lirong

Beijing Chao-Yang Hospital, Capital Medical University

llrcruie@163.com+86 10 85231547

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026